Hong Kong’s CR-CP Life Science Fund Leads $22M Series C2 Round In US Biotech Firm
April 29, 2019 — 10:12 CST
This Data Is Locked!
This area is available only to Subscribers.
American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals